Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible

Table 1 Characteristics of patients with neuroendocrine liver metastases treated in the HEPAR PLuS trial, included in this study

Characteristics	N or median
N patient	29
Pre-treatment Post-treatment	26 32^‡
Sex
Male Female	21 8
Age (years)^*	63 ± 8
Treatment type	Pre-treatment	Post-treatment
Whole liver Partial liver	21^† 5	15^† 17